about
Non-steroid agents for idiopathic pulmonary fibrosisNew perspectives on management of idiopathic pulmonary fibrosisClinical trials of investigational agents for IPF: a review of a Cochrane reportUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementPulmonary fibrosis: pathogenesis, etiology and regulationWorkshop on idiopathic pulmonary fibrosis in older adultsFibrocytes and the pathogenesis of diffuse parenchymal lung disease.Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data.Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells.Is there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise.Accumulation of BDCA1⁺ dendritic cells in interstitial fibrotic lung diseases and Th2-high asthma.An integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesCurcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injuryEffect of treatment guidelines on the initial management of idiopathic pulmonary fibrosisClinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatmentBaicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathwayMolecular and cellular mechanisms of pulmonary fibrosis.Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysisPharmacologic therapies for idiopathic pulmonary fibrosis, past and future.A review of current and novel therapies for idiopathic pulmonary fibrosisMacrophage heterogeneity in respiratory diseases.Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-S-transferase π.Therapies for interstitial lung disease: past, present and future.Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF).Approach to acute exacerbation of idiopathic pulmonary fibrosis.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis.Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis.Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study
P2860
Q24235478-7E6CB02E-9766-43AE-B33A-0C7FDC8566E0Q26765586-1660920D-203F-4734-8D57-51254519769EQ26823161-7DF72B17-D0E1-4E7C-8EC6-5F67A74636A8Q28083702-EA49F522-91EF-4D7F-9BCA-E4127D5103B6Q28308246-208E49B9-97D0-4E6E-AFA2-DE1E9499315CQ28388425-59257DE4-EF1F-466C-B5E7-261B3AD82BA0Q28603445-1AB2F9D9-869F-492C-957A-C94D26632408Q30426516-D90A56ED-FB36-469F-9988-EEC71F1F6F9EQ31161630-C4C0CFFC-7768-4BF2-8E5B-66BE967B04E9Q33236654-A44556E8-D85C-4815-834B-E088BF9D517EQ33278156-D5F88608-0595-4A64-918A-5B9B18EC5356Q33734288-C3AA2694-AA39-4ADF-AD9C-D7CF04651BD4Q33766956-11880BD8-DBFC-4395-92D1-2759ED2CB28DQ33840489-E9CAC0D6-B7FD-40A8-81F5-6B623FAE3AF9Q34019374-8EF28BB6-5592-47DB-A6CE-EB9233728833Q35561400-8CDB9F0F-D2A3-4DBB-929D-95D9BAFFCD81Q35840808-CEA167C6-05BF-426C-A756-B7FDDD3ACEA8Q36141637-291680A1-829E-4DF5-B0A1-3C485B7C1B88Q36237168-A4BCEA14-635F-4CBD-BF10-1B827B1B6FD5Q36252121-8605382F-E5C0-44C9-83CF-4AF4B2599972Q36264068-F02AFF62-D998-4177-BE68-CBB989FEF676Q36542274-673EE598-51C5-4C1C-A848-5619D1B6DA66Q36692041-6F9D68EC-F61E-4B47-97BE-A7E67F3D840FQ37041521-992FF115-2DB8-40FB-B2DD-30C00E7D5973Q37362642-91986D0A-5832-4CA6-93EE-5CE40249BCE4Q38247265-08A2A7FA-F763-4139-87F8-857B6354565CQ38461691-F05DECCD-280B-4EAF-B11F-F3A3EC594ED5Q38833606-6CE2C357-D59D-4E97-B5FE-A2F9C4EA6ABEQ41090863-13D37136-F243-4EC9-8B13-050B59070F67Q41194552-EB21F0C9-6DB0-4CE6-A4AE-69A53EDD94D5Q42694416-9D881426-557B-4CD0-9D5E-F8556565E01CQ47660678-886203E6-D4C1-4824-833F-B6E193F92A61Q55114038-FFA4E2C3-5EB9-4CAD-BF9F-2EC93CE82AECQ58577800-57D2CF9B-98CF-4D7E-9367-CD1735E148C7
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Corticosteroids for idiopathic pulmonary fibrosis
@ast
Corticosteroids for idiopathic pulmonary fibrosis
@en
Corticosteroids for idiopathic pulmonary fibrosis
@en-gb
Corticosteroids for idiopathic pulmonary fibrosis
@nl
type
label
Corticosteroids for idiopathic pulmonary fibrosis
@ast
Corticosteroids for idiopathic pulmonary fibrosis
@en
Corticosteroids for idiopathic pulmonary fibrosis
@en-gb
Corticosteroids for idiopathic pulmonary fibrosis
@nl
prefLabel
Corticosteroids for idiopathic pulmonary fibrosis
@ast
Corticosteroids for idiopathic pulmonary fibrosis
@en
Corticosteroids for idiopathic pulmonary fibrosis
@en-gb
Corticosteroids for idiopathic pulmonary fibrosis
@nl
P2093
P2860
P3181
P1476
Corticosteroids for idiopathic pulmonary fibrosis
@en
P2093
Fabrizio Luppi
Huw Richard H R Davies
Paolo Spagnolo
P2860
P3181
P356
10.1002/14651858.CD002880
P577
2003-07-21T00:00:00Z